Back to search

Switzerland· 62309010

Vascord HCT 40/10/25mg, Filmtabletten

A olmesartan medoxomil, amlodipin und hydrochlorothiazid product containing olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum, registered in Switzerland by A. Menarini GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DX03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVascord HCT 40/10/25mg, FilmtablettenATCC09DX03REGISTER NO.62309010PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.

Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum
Manufacturer
A. Menarini GmbH
Country
Switzerland (CH)
ATC code
C09DX03
ATC class
Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680623090102
    98 Stk
    CHF 82.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record

36 records

36 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil, amlodipin und hydrochlorothiazid in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil, amlodipin und hydrochlorothiazid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee956ff8-7ea9-4c7f-9851-611c6888899d
GET /v1/drugs/ee956ff8-7ea9-4c7f-9851-611c6888899d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "olmesartani medoxomilum 40 mg + amlodipinum 10 mg + hydrochlorothiazidum 25 mg",
  "valid_from": "2011-11-01",
  "limitations": "[{\"description\":\"Die gleichzeitige Therapie mit VASCORD/HCT und einem Calciumantagonisten des I.T. 02.06 und/oder einem Angiotensin-II-Antagonisten und/oder einem ACE-Hemmer wird von der obligatorischen Krankenpflegeversicherung nicht vergütet.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-10-01\"}]",
  "galenic_form": "Filmtabl 40/10/25 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2011-11-01",
  "self_retention_pct": 10
}

See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.